Sequence variations in human immunodeficiency virus (HIV)-1 reverse transcriptase (RT) and protease, the molecular targets of anti-retroviral drug therapy, are prime examples of genes in which ...

On board the W-1 was an invaluable payload—space-produced ritonavir crystals that can be employed in the treatment of HIV. This organic compound inhibits the HIV protease in the human body ...

The treatment of hyperlipidemia in patients infected with HIV is discussed. Hyperlipidemia is common in HIV-infected patients receiving antiretroviral therapy, especially protease inhibitors and ...

In our 35th year we’re asking people to donate £35 – that’s just £1 for every year we’ve been ... target one of three viral proteins which control HIV’s lifecycle: reverse transcriptase, integrase and ...

Among the CCR5 inhibitors developed so far, maraviroc is the first drug that has been approved by the US FDA for treating patients with R5 HIV-1. Although many CXCR4 inhibitors, some of which are ...

Lupin gained 3.66% to Rs 2,188 after the company announced that it has received a tentative approval from the U.S. Food and Drug Administration (USFDA) for its ANDA for Darunavir, Cobicistat, ...